AZD0486 demonstrated encouraging safety and dose-dependent efficacy in heavily pretreated adolescent and adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia (ALL), according to ...

In the fight against cancer, immunotherapy - which aims to boost the body's natural defences against cancer - is experiencing remarkable growth. Most of these treatments are based on CD8 T lymphocytes ...

Scientists say they captured 3D images of a new organelle they're calling a "hemifusome," which may be a recycling center in ...

It's easy to fall short on this mineral. Avoid trouble by getting more of these ample food sources of iron in your diet.

Three major Mount Sinai research studies offer new hope for patients facing chronic lymphocytic leukemia (CLL), a rare type ...

Free-floating DNA carrying cancerous mutations was detected in blood three years before any other signs of cancer appeared.

Specifically, the FDA removed the Risk Evaluation and Mitigation Strategy (REMS) program requirements from two BCMA-directed CAR T-cell therapies for multiple myeloma — ciltacabtagene autoleucel ...

Dr. Soma Mandal, a board-certified internist at Summit Health in New Providence, New Jersey, says that getting a CBC test is ...

Bristol Myers Squibb has announced that the FDA has given approval to label updates for Breyanzi and Abecma to treat multiple myeloma.

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...

A new blood test can detect leukemia and blood aging risks non-invasively, potentially replacing painful bone marrow biopsies ...